ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)

Generic Name: pancrelipase

Pill imprint ETH 416 has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U.

Plaretase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not a controlled substance under the Controlled Substance Act (CSA).

Plaretase

Generic Name:

pancrelipase

Imprint:

ETH 416

Strength:

Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U

Color:

Tan

Shape:

Round

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Ethex Corporation

National Drug Code (NDC):

58177-0416

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.